Historical Stock Price
PRQR historical stock prices picture
ProQR Therapeutics N.V. (PRQR) has the following price history information. Looking back at PRQR historical stock prices for the last five trading days, on April 22, 2024, PRQR opened at $1.99, traded as high as $2.10 and as low as $1.97, and closed at $2.00. Trading volume was a total of 113.10K shares. On April 23, 2024, PRQR opened at $2.01, traded as high as $2.12 and as low as $1.99, and closed at $2.02. Trading volume was a total of 185.50K shares. On April 24, 2024, PRQR opened at $2.02, traded as high as $2.04 and as low as $1.97, and closed at $2.01. Trading volume was a total of 36.40K shares. On April 25, 2024, PRQR opened at $1.97, traded as high as $2.03 and as low as $1.84, and closed at $1.96. Trading volume was a total of 239.00K shares. On April 26, 2024, PRQR opened at $1.95, traded as high as $1.99 and as low as $1.93, and closed at $1.94. Trading volume was a total of 50.80K shares.

PRQR Historical Stock Prices By Date:

PRQR historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ProQR Therapeutics N.V. shares, starting with a $10,000 purchase of PRQR, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/18/2014
End date: 04/26/2024
Start price/share: $14.73
End price/share: $1.94
Dividends collected/share: $0.00
Total return: -86.83%
Average Annual Total Return: -19.02%
Starting investment: $10,000.00
Ending investment: $1,316.51
Years: 9.61
Date Open High Low Close Volume
04/22/2024 $1.99 $2.10 $1.97 $2.00 113.10K
04/23/2024 $2.01 $2.12 $1.99 $2.02 185.50K
04/24/2024 $2.02 $2.04 $1.97 $2.01 36.40K
04/25/2024 $1.97 $2.03 $1.84 $1.96 239.00K
04/26/2024 $1.95 $1.99 $1.93 $1.94 50.80K
ProQR Therapeutics is a clinical stage biopharmaceutical company. Co. is developing a pipeline of RNA therapies for inherited retinal diseases. Beyond its clinical portfolio, Co. has discovered and developed two proprietary RNA editing platform technologies, Axiomer and TRIDENT™. Co.'s editing oligonucleotides are designed to recruit endogenous Adenosine Deaminases Acting on RNA, enzymes to make single nucleotide changes in the RNA in a manner at a desired location. TRIDENT is Co.'s RNA pseudouridylation platform that enables the selective suppression of nonsense mutations that cause human genetic disease.
Date Close
04/22/2024$2.00
04/23/2024$2.02
04/24/2024$2.01
04/25/2024$1.96
04/26/2024$1.94

PRQR Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.